John Kirkwood, MD
UPMC Hillman Cancer Center · University of Pittsburgh · University of Pittsburgh Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name John Kirkwood, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:49 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT04688658 · Duvelisib in Combination With Nivolumab in Patients With Advanced Unresectable MelanomaJohn Kirkwood · terminated · Unresectable Melanoma · principal investigator
- Ph2NCT03743766 · Nivolumab, BMS-936558 in Combination With Relatlimab, BMS-986016 in Patients With Metastatic Melanoma Naïve to Prior Immunotherapy in the Metastatic SettingJohn Kirkwood · completed · Melanoma · principal investigator
- N/ANCT02058953 · CNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain MetastasesUniversity of Pittsburgh · completed · Melanoma, Brain Metastases · principal investigator
- Ph1NCT01943422 · Safety and Efficacy Study of Vemurafenib and High-dose Interferon Alfa-2b in MelanomaJohn Kirkwood · completed · Melanoma · principal investigator
- Ph2NCT01876212 · Dendritic Cell Vaccines + Dasatinib for Metastatic MelanomaWalter J. Storkus · completed · Metastatic Melanoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:49 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 9 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Combinational Immunotherapy Targeting the Melanoma-Associated VasculatureR01CA169118 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Walter J. Storkus · fiscal years 2012 to 2016Named on NCT01876212
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.